Anaphylactic Reaction Induced By Paclitaxel in the Treatment of Non-Small Cell Lung Cancer (NSCLC)

Journal Title: International Journal of Clinical & Medical Allergy (IJCMA) - Year 2013, Vol 1, Issue 1

Abstract

Most systemic chemotherapic agents used in lung cancer treatment can lead to hypersensitivity reactions, of varying degrees of severity. In absence of laboratory tests (such as elevated serum total tryptase or/and plasma histamine levels).Distinguishing between anaphylaxis and acute infusion reactions is impossible since their symptoms are identical. Few Paclitaxel hypersensitivity reactions described in literature are documented in the absence of standardized tests to chemotherapeutics drugs and since not all suspected patients undergo allergological tests. A 74 years old female patient, with history of Inobitriol induced laryngeal angioedema and right middle lobe NSCLC, developed a moderate anaphylactic reaction during Paclitaxel second administration. Infusion suspension and symptomatic treatments led to rapid symptoms remission. Prick tests to Paclitaxel were negatives but the intradermal reaction was positive, as well as basophile activation test. The mechanism of paclitaxel-associated hypersensitivity reaction is uncertain and its solvent vehicle may be involved; in case of paclitaxel immediate hypersensitivity reaction, we recommend tryptase and/or histamine serum levels quantification to confirm the acute anaphylaxis episode and realization of allergologicals tests to Paclitaxel and its solvent vehicle (skin tests ± challenge test) 3 to 4 weeks after the incident. Rapid desensitization is possible for both Ig-E mediated and non-Ig-E mediated immediate hypersensitivity reactions to Paclitaxel.

Authors and Affiliations

A. Tiotiu

Keywords

Related Articles

Study of the Correlation Between Bronchial Hyperresponsiveness and Exhaled Nitric Oxide in Subjects with Suspected Symptoms of Asthma

Background: Bronchial hyperresponsiveness (BHR) is one of main features of asthma within chronic inflammation and reversible bronchoconstriction. Actually, methacholine challenge is useful method to detect BHR in subject...

Occupational Exposure During Pregnancy and the Risk of Atopic Dermatitis in the Offspring

Background: The prevalence of atopic dermatitis (AD) has increased considerably in the last decades. The major predisposing factor for AD is an inherited epithelial barrier defect due to loss-of-function in the filaggrin...

Immune Response Profiles During Asthma Attacks and Intercritical Periods In Children

Asthma is a serious public health problem due to its socioeconomic impact worldwide and affects over three hundred million individuals. This chronic inflammatory airway disease causes hyperresponsiveness, obstruction, in...

Social Stigma, Discrimination, Marginalization and Prejudice towards Persons with Tuberculosis: A Systematic Review Study

Tuberculosis is one of the most commonly diseases in India. It is a highly infectious disease and most commonly affects the lungs of a person. Tuberculosis (TB) is an infectious disease caused by a Bacterium, Mycobacteri...

Risk Factors Exposure during the First Life Year and Asthma Development among Albanian Children

Background: Different environmental factors are accused as risk factors (RF) in the development of allergic respiratory diseases. This study aimed to investigate the role of exposure to suspected RFs during the first lif...

Download PDF file
  • EP ID EP214013
  • DOI 10.19070/2332-2799-130001
  • Views 92
  • Downloads 0

How To Cite

A. Tiotiu (2013). Anaphylactic Reaction Induced By Paclitaxel in the Treatment of Non-Small Cell Lung Cancer (NSCLC). International Journal of Clinical & Medical Allergy (IJCMA), 1(1), 1-2. https://www.europub.co.uk/articles/-A-214013